Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · March 30, 2012

What Cost and What Gain: 1 Year of Trastuzumab in Canada

The Oncologist

 

Additional Info

The Oncologist
Assessing the Real-World Cost-Effectiveness of Adjuvant Trastuzumab in HER-2/neu Positive Breast Cancer
Oncologist 2012 Feb 02;[EPub Ahead of Print], L Hedden, S O'Reilly, C Lohrisch, S Peacock, et al

Further Reading